Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of a routinely used compounded
liquid formulation of 6-mercaptopurine (6-MP) with commercially available tablets in patients
who are receiving treatment with 6-MP as part of their clinical treatment for acute
lymphoblastic leukemia (ALL).
Details
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborators:
Experimental Therapeutics in Pediatric Oncology Program at The Children's Mercy Hospitals and Clinics Midwest Cancer Alliance